The following are our studies currently being enrolled. Please fill out the form below to enroll.
Cholesterol Lipoprotein (a) Study: - History of cardiovascular disease (heart attack and/or stents with an underlying comorbidity condition) and very elevated Lp(a) concentration - Subjects should also be currently taking a statin or documented statin intolerance
Heart Failure Study: - Diagnosis of heart failure (NYHA Class II-IV) - LVEF > 40% documented by echocardiography within 12 months
Hypertension with Chronic Kidney Disease: - Systolic Blood Pressure over 140 - Mild to moderate Chronic Kidney Disease (eGFR between 25 and 75) - Must be taking an ACE or an ARB
COPD (Chronic Obstructive Pulmonary Disease): - Eosinophil count greater than 300 - Use of ICS-based triple COPD standard of care - At least 2 moderate COPD exacerbations within 12 months
Weight Loss: - Age 55 or above - Established Cardiovascular Disease (prior MI{myocardial infarction}/heart attack, prior stroke, symptomatic peripheral arterial disease {PAD}) - No heart attack, stroke, or hospitalization for unstable angina or transient ischemic attack within 60 days prior to screening - No treatment with any GLP-1 medications within 90 days before screening - No major depressive disorder, severe psychiatric disorder, or history of suicidal attempt - No history of pancreatitis
Migraine study: Over 18 years of age 1 year history of chronic migraine Age of onset of migraines prior to 50 years of age. Migraine attacks lasting 4 -72 hours if untreated. At least 15 headache days per month over the last 3 months.
Hypertriglyceridemia/Very High Triglycerides: Research Study for patients that have triglycerides over 500 on more than one occasion and on a statin medication
Women’s Ischemia Trial: Females must have a normal heart catheterization within 5 years but have signs and/or symptoms of heart issues (chest pain, shortness of breath, etc.)
Cardiovascular Disease, Chronic Kidney Disease, Systemic Inflammation: - Age ≥ 18 - eGFR ≥ 15 and < 60 - MI, cardiac revascularization, ≥50% stenosis in major coronary artery, stroke, carotid revascularization, ≥50% stenosis in carotid artery, peripheral arterial disease (PAD) with claudication (from ABI testing), PAD with ≥ 50% stenosis, peripheral artery revascularization, or lower extremity amputation at or above the ankle due to atherosclerotic disease - No chronic or intermittent dialysis - No diagnosis of HIV, HEP C, or HEP B